ENO1 activates intracellular p38 MAPK and NF-κB pathways, which leads to elevated levels of pro-inflammatory mediators involved in RA, such as IL-1β, IL-6, and TNF-α (104). Here, NFKB1 is linked to rheumatoid arthritis.